CellCept 250 Roche Pill - orange & turquoise capsule/oblong, 19mm
Generic Name: mycophenolate mofetil
Pill with imprint CellCept 250 Roche is Orange & Turquoise, Capsule/Oblong and has been identified as CellCept 250 mg. It is supplied by Roche Laboratories.
CellCept is used in the treatment of Organ Transplant, Rejection Prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. CellCept 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CellCept 250 Roche




CellCept
- Generic Name
- mycophenolate mofetil
- Imprint
- CellCept 250 Roche
- Strength
- 250 mg
- Color
- Orange & Turquoise
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Roche Laboratories
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
povidone k90,
corn starch,
FD&C Blue No. 2,
ferric oxide yellow,
ferric oxide red,
titanium dioxide,
silicon dioxide,
sodium lauryl sulfate,
shellac,
potassium hydroxide,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00004-0259 | Roche |
49999-0936 (Discontinued) | Lake Erie Medical and Surgical Supply (repackager) |
More about CellCept (mycophenolate mofetil)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
- Cellcept drug information
- Cellcept (Mycophenolate Intravenous) (Advanced Reading)
- Cellcept (Mycophenolate mofetil Oral) (Advanced Reading)
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.